Mayer WJ - Search Results

1

Using Electronic Health Records to Build an Ophthalmologic Data Warehouse and Visualize Patients' Data.

Kortüm KU, Müller M, Kern C, Babenko A, Mayer WJ, Kampik A, Kreutzer TC, Priglinger S, Hirneiss C. Kortüm KU, et al. Among authors: mayer wj. Am J Ophthalmol. 2017 Jun;178:84-93. doi: 10.1016/j.ajo.2017.03.026. Epub 2017 Mar 30. Am J Ophthalmol. 2017. PMID: 28365240

2

[Persistent contact lens-associated keratitis].

Klingenstein A, Mayer WJ, Rueping J, Miller C, Kampik A, Mino De Kaspar H. Klingenstein A, et al. Among authors: mayer wj. Ophthalmologe. 2011 Dec;108(12):1164-7. doi: 10.1007/s00347-011-2408-8. Ophthalmologe. 2011. PMID: 21842291 German.

3

[Progressive visual loss and muscular weakness in a young patient].

Remy M, Mayer WJ, Kampik A, Rudolph G. Remy M, et al. Among authors: mayer wj. Klin Monbl Augenheilkd. 2012 Mar;229(3):259-61. doi: 10.1055/s-0031-1273412. Epub 2011 Aug 16. Klin Monbl Augenheilkd. 2012. PMID: 21847786 German. No abstract available.

4

Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.

Mayer WJ, Hakim I, Haritoglou C, Gandorfer A, Ulbig M, Kampik A, Wolf A. Mayer WJ, et al. Acta Ophthalmol. 2013 May;91(3):274-8. doi: 10.1111/j.1755-3768.2011.02264.x. Epub 2011 Sep 22. Acta Ophthalmol. 2013. PMID: 21952010 Free article.

5

Distribution of antigen presenting cells in the human cornea: correlation of in vivo confocal microscopy and immunohistochemistry in different pathologic entities.

Mayer WJ, Mackert MJ, Kranebitter N, Messmer EM, Grüterich M, Kampik A, Kook D. Mayer WJ, et al. Curr Eye Res. 2012 Nov;37(11):1012-8. doi: 10.3109/02713683.2012.696172. Epub 2012 Jun 5. Curr Eye Res. 2012. PMID: 22667765

6

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C. Mayer WJ, et al. Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23. Ophthalmologica. 2012. PMID: 22739239 Free article.

7

EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.

Wertheimer C, Liegl R, Kernt M, Mayer W, Docheva D, Kampik A, Eibl-Lindner KH. Wertheimer C, et al. Graefes Arch Clin Exp Ophthalmol. 2013 Jun;251(6):1529-40. doi: 10.1007/s00417-013-2257-z. Epub 2013 Jan 18. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23329402

8

Modification of amniotic membrane as a depot carrier for bevacizumab - an in-vitro model for a slow release mechanism.

Mayer WJ, Grüterich M, Kook D, Sigg W, Kernt M, Messmer EM, Haritoglou C, Kampik A, Wolf A. Mayer WJ, et al. Curr Eye Res. 2013 Apr;38(4):445-50. doi: 10.3109/02713683.2012.757326. Epub 2013 Feb 13. Curr Eye Res. 2013. PMID: 23405870

9

Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion.

Mayer WJ, Wolf A, Kernt M, Kook D, Kampik A, Ulbig M, Haritoglou C. Mayer WJ, et al. Eye (Lond). 2013 Jul;27(7):816-22. doi: 10.1038/eye.2013.79. Epub 2013 Apr 19. Eye (Lond). 2013. PMID: 23598674 Free PMC article.

10

Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab.

Wolf A, Rüping J, Neubauer AS, Mayer W, Ulbig M, Haritoglou C, Holz FG, Eter N, Kampik A. Wolf A, et al. Retina. 2013 Oct;33(9):1843-9. doi: 10.1097/IAE.0b013e318287d9be. Retina. 2013. PMID: 23598795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters